Database research and development often require a large number of SQL queries for benchmarking purposes. However, acquiring real-world SQL queries is challenging due to privacy concerns, and existing ...
Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results